Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
IVVD
#2829
Invivyd, Inc. Common Stock
1.6
9
-1.17%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-1.17%
Monatliche Änderung
-17.56%
6 month change
+74.23%
Jahresänderung
+40.83%
Vorheriger Schlusskurs
1.7
1
Open
1.6
9
Bid
Ask
Low
1.6
9
High
1.6
9
Volumen
53
Märkte
Aktien
Gesundheitswesen
IVVD
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
119.62 M
119.96 M
119.96 M
120.14 M
233.12 M
—
Valuation ratios
Enterprise value
15.14 M
-16.19 M
24.53 M
51 M
171.47 M
230.81 M
Price to earnings ratio
-0.52
-0.31
-0.51
-0.79
-2.39
-4
Price to sales ratio
—
2.07
1.97
1.85
2.85
8.73
Price to cash flow ratio
0.61
0.31
0.51
0.75
1.69
3.26
Price to book ratio
0.2
0.78
0.21
0.34
0.57
1.9
Enterprise value to EBITDA ratio
—
0.09
—
—
—
—
Profitability ratios
Return on assets %
0.38
0.14
0.16
0.16
0.08
0.54
Return on equity %
0.73
0.27
0.3
0.34
0.11
1.03
Return on invested capital %
2 627.35
362.64
229.4
201.48
143.5
937.02
Gross margin %
100
92.16
97.29
98.72
98.87
387.03
Operating margin %
670.01
139.14
149.7
127.78
83.96
500.58
EBITDA margin %
—
-141.74
—
—
—
—
Net margin %
653.11
133.45
144.1
124.38
79.75
481.68
Liquidity ratios
Quick ratio
1.58
1.21
1.02
0.76
1.9
4.88
Current ratio
1.92
1.62
1.53
1.33
2.47
6.95
Inventory turnover
—
0.04
0.01
0.01
0.01
0.06
Asset turnover
0.05
0.09
0.1
0.12
0.12
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
6.18
7.72
9.64
11.22
7.19
35.76
Long term debt to total equity ratio
12.02
14.81
18.47
23.37
10.74
67.39
Per share metrics
Operating cash flow per share
0.34
0.32
0.18
0.11
0.05
0.65
EBIT per share
—
-0.17
-0.14
-0.12
-0.06
-0.48
EBITDA per share
—
-0.17
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.89
0.58
0.4
0.29
0.5
1.78
Net current asset value per share
1.26
0.85
0.63
0.49
0.65
2.62
Tangible book value per share
0.7
0.57
0.45
0.36
0.55
1.92
Working capital per share
0.61
0.33
0.22
0.12
0.38
1.05
Book value per share
0.7
0.57
0.45
0.36
0.55
1.92
Nachrichten
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Invivyd: Personalvorständin Green verkauft Aktien im Wert von 63.000 $
Invivyd (IVVD) CHRO Green sells $63k in stock after option exercise
Invivyd: Wissenschaftsvorstand Allen veräußert Aktien im Wert von 58.600 US-Dollar/n
Invivyd CSO Allen sells shares worth $58,600
Halozyme Therapeutics (HALO) Reports Q4 Loss, Tops Revenue Estimates
H.C. Wainwright bestätigt Kaufempfehlung für Invivyd-Aktie nach FDA-Feedback
H.C. Wainwright reiterates Buy rating on Invivyd stock amid FDA feedback
Invivyd: FDA gibt Vorgaben für Vergleichsstudie von COVID-Antikörper und mRNA-Impfstoff
Invivyd receives FDA feedback on COVID antibody vs mRNA vaccine trial
H.C. Wainwright bekräftigt Kaufempfehlung für Invivyd vor wichtigen Studiendaten